Is the award cash?
+
No. Each of the three awards is up to $20,000 in scoped, in-kind SPARC drug-discovery services — commitments of expertise and computation, not a cash grant. SPARC and each selected team jointly define the scope, deliverables, responsibilities, milestones, and timeline.
Who has to be on the team?
+
At least one co-investigator whose primary institutional affiliation is UAB or an institution in the UAB-led CCTS Partner Network. Other members may come from any institution or organization. See the
CCTS Partner Network list.
What do we submit, and how?
+
A concise three-page proposal covering the unmet need, central hypothesis, scientific foundation, proposed solution, SPARC support requested, team readiness, validation plan, and next milestone. Submission is through the designated CollaboFest collaboration portal and is required for all contestants.
What does the award not cover?
+
Unless specifically included in the final scope, awards should not be assumed to cover compound synthesis or purchase, wet-lab experiments, animal studies, clinical recruitment, IRB or regulatory submissions, patent expenses, or third-party fees. SPARC may help design or connect these downstream activities under a separate agreement.
How are winners chosen?
+
SPARC uses automated, agent-assisted reviews as decision support for consistent preliminary assessment. A panel of judges from SPARC, DBIDS, the Heersink Institute, Southern Research, and the UAB-led CCTS reviews the evidence and recommends the final winners. Criteria for the Grand Prize will be announced separately.
Who owns the intellectual property?
+
Teams should identify relevant background IP, prior disclosures, restricted data, and potential inventorship considerations. Data access, privacy, security, publication, authorship, and IP matters follow applicable UAB policies and project-specific agreements.